Singapore markets closed
Straits Times Index
3,292.93 -3.96 (-0.12%) Nikkei
38,236.07 -37.98 (-0.10%) Hang Seng
18,475.92 +268.79 (+1.48%) FTSE 100
8,213.49 +41.34 (+0.51%) Bitcoin USD
62,722.35 +3,037.25 (+5.09%) CMC Crypto 200
1,359.39 +82.41 (+6.45%)
Sol-Gel Technologies Ltd. (SLGL)
NasdaqGM - NasdaqGM Delayed price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 0.8500 |
| Open | 0.8700 |
| Bid | 0.0000 x 0 |
| Ask | 0.0000 x 0 |
| Day's range | 0.8268 - 0.8700 |
| 52-week range | 0.6820 - 4.0500 |
| Volume | |
| Avg. volume | 30,420 |
| Market cap | 23.69M |
| Beta (5Y monthly) | 1.32 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Simply Wall St.
Sol-Gel Technologies Full Year 2023 Earnings: Revenues Beat Expectations, EPS In Line
Sol-Gel Technologies ( NASDAQ:SLGL ) Full Year 2023 Results Key Financial Results Net loss: US$27.2m (loss widened by...
- Zacks
Zacks Industry Outlook Highlights Dr. Reddy's Laboratories, Amphastar Pharmaceuticals and Sol-Gel Technologies
Dr. Reddy's Laboratories, Amphastar Pharmaceuticals and Sol-Gel Technologies are part of the Zacks Industry Outlook article.
- Zacks
3 Generic Drug Stocks to Watch Amid Improving Market Prospects
The impact of macroeconomic headwinds on the Zacks Medical - Generic Drugs industry is gradually improving. New product launches provide some respite to RDY, AMPH and SLGL.
© 2024 Yahoo. All rights reserved.